SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001562762-23-000324
Filing Date
2023-08-09
Accepted
2023-08-09 07:30:29
Documents
76
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vaxx-20230630.htm   iXBRL 10-Q 1168271
2 EX-31.1 exhibit311.htm EX-31.1 11825
3 EX-31.2 exhibit312.htm EX-31.2 11967
4 EX-32.1 exhibit321.htm EX-32.1 6191
  Complete submission text file 0001562762-23-000324.txt   6507192

Data Files

Seq Description Document Type Size
5 EX-101.CAL vaxx-20230630_cal.xml EX-101.CAL 67585
6 EX-101.DEF vaxx-20230630_def.xml EX-101.DEF 411021
7 EX-101.LAB vaxx-20230630_lab.xml EX-101.LAB 708853
8 EX-101.PRE vaxx-20230630_pre.xml EX-101.PRE 526847
9 EX-101.SCH vaxx-20230630.xsd EX-101.SCH 75483
70 EXTRACTED XBRL INSTANCE DOCUMENT vaxx-20230630_htm.xml XML 715881
Mailing Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953
Business Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953 (254) 244-5739
Vaxxinity, Inc. (Filer) CIK: 0001851657 (see all company filings)

IRS No.: 862083865 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41058 | Film No.: 231153382
SIC: 2834 Pharmaceutical Preparations